The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Abstract
The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are the most abundant G-protein-coupled receptors in the central nervous system12, 13”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [12]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500
Research works printed but not linked: 9
- Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
- Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
- Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
- Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
- Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
- Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
- Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
- Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
- Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42
Cited by
Sorted by citations
Items 701–800 of 1,000
Rojo, M. L., Söderström, I., Olsson, T., & Fowler, C. J. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.02.002 · Cited by 9
Harris, J. C., Wallace, A. L., Thomas, A. M., Wirtz, H. G., Kaiver, C. M., & Lisdahl, K. M. (2022) · Brain Sciences · doi:10.3390/brainsci12020287 · Cited by 9
Role of the amygdala and possible biomarkers in psychiatric disorders
Flores, G., Reyes-Lizaola, S., Aguilar‐Hernández, L., Gil‐Velazco, A., Tendilla‐Beltrán, H., & Morales‐Medina, J. C. (2024) · NeuroMarkers. · doi:10.1016/j.neumar.2024.100032 · Cited by 12
Coppola, M., & Mondola, R. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.016 · Cited by 9
Rafei, P., Rezapour, T., Batouli, S. A. H., Verdejo‐García, A., Lorenzetti, V., & Hatami, J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06002-7 · Cited by 9
Galaj, E., Hempel, B. J., Moore, A. R., Klein, B., Bi, G., Gardner, E. L., Seltzman, H. H., & Xi, Z. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02059-w · Cited by 9
Toward the design of cannabinoid CB1receptor inverse agonists and neutral antagonists
Reggio, P. H. (2009) · Drug Development Research · doi:10.1002/ddr.20337 · Cited by 9
Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats
Méndez‐Díaz, M., Caynas-Rojas, S., Armas, D. G., Ruiz‐Contreras, A. E., Aguilar‐Roblero, R. A., & Prospero-Garcia, O. E. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.11.010 · Cited by 9
Laricchiuta, D., Rojo, M. L., Rodríguez‐Gaztelumendi, A., Ferlazzo, F., Petrosini, L., & Fowler, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042111 · Cited by 9
Endocannabinoid Signaling in Neural Circuits of the Olfactory and Limbic System
Heinbockel, T., Wang, Z., Brown, E. A., & Austin, P. T. (2016) · InTech eBooks · doi:10.5772/63214 · Cited by 9
Rock, E. M., Limebeer, C. L., Aliasi‐Sinai, L., & Parker, L. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.031 · Cited by 9
The Consequences of Marijuana Use During Pregnancy: A Review of the Human Literature
Fried, P. A. (2002) · Journal of Cannabis Therapeutics · doi:10.1300/j175v02n03_06 · Cited by 9
Potvin, S., Vincenot, M., Haroune, L., Giguère, C., Gendron, L., Léonard, G., & Marchand, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-67401-2 · Cited by 8
Dendritische Nanostrukturen zur rezeptorvermittelten Aufnahme von siRNA in neurale Zellen
Brunner, K., Harder, J., Halbach, T. S., Willibald, J., Spada, F., Gnerlich, F. A., Sparrer, K. M. J., Beil, A., Möckl, L., Bräuchle, C., et al. (2014) · Angewandte Chemie · doi:10.1002/ange.201409803 · Cited by 8
Neurotransmitter and receptor systems in the subthalamic nucleus
Emmi, A., Campagnolo, M., Stocco, E., Carecchio, M., Macchi, V., Antonini, A., De, R., & Porzionato, A. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02678-z · Cited by 8
Neurocognitive moderation of associations between cannabis use and psychoneuroticism
Huijbregts, S. C. J., Griffith‐Lendering, M. F. H., Vollebergh, W., & Swaab, H. (2014) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2014.943694 · Cited by 11
Impaired P100 among regular cannabis users in response to magnocellular biased visual stimuli
Rémy, I., Schwitzer, T., Albuisson, É., Schwan, R., Krieg, J., Bernardin, F., Ligier, F., Lalanne, L., Maillard, L. G., & Laprévote, V. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110437 · Cited by 9
Mazza, M., Caroppo, E., Marano, G., Kotzalidis, G. D., Avallone, C., Camardese, G., Janiri, D., Moccia, L., Simonetti, A., Janiri, L., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127397 · Cited by 8
Glenn, N. A. K., Finlay, D. B., Carruthers, E. R., Mountjoy, K. G., Walker, C. S., & Grimsey, N. L. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16095 · Cited by 8
Langfristige Folgen des chronischen Cannabiskonsums
Schneider, M. (2004) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/2004.05.04 · Cited by 8
Umut, G., Atagün, M. İ., Evren, C., Cengel, H. Y., Hisim, O., & Keskinkılıç, C. (2016) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20151019014343 · Cited by 8
Role of cannabinoids in the treatment of Tinnitus
Plescia, F., Brancato, A., Martines, F., Cannizzaro, E., Plescia, F., Cannizzaro, C., Salvago, P., Martini, A., Mucia, M., & Rizzo, S. (2016) · Nova Science Publishers (Nova Science Publishers, Inc.) · doi:10.19193/0393-6384_2016_4_108 · Cited by 8
Loren Parsons' contribution to addiction neurobiology
Luca, M. A. D., Buczynski, M. W., & Chiara, G. D. (2018) · Addiction Biology · doi:10.1111/adb.12642 · Cited by 8
Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?
Stoecker, W. V., Rapp, E. E., & Malters, J. M. (2018) · Europe PMC (PubMed Central) · Cited by 8
Sadeghi-Adl, M., Sadat‐Shirazi, M., Shahini, F., Akbarabadi, A., Khalifeh, S., Borzabadi, S., Nasehi, M., & Zarrindast, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118430 · Cited by 8
Dynamics of the accommodative response after smoking cannabis
Ortiz‐Peregrina, S., Ortíz, C., Martino, F., Castro, J. J., & Anera, R. G. (2021) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12851 · Cited by 8
Grant, P. S., Kahlcke, N., Govindpani, K., Hunter, M. R., Macdonald, C. E., Brimble, M. A., Glass, M., & Furkert, D. P. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126644 · Cited by 8
Self-citationRaymon, L. P., & Walls, H. C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-947-9_5 · Cited by 8
Experimental Methods to Study the Role of the Peripheral Cannabinoid Receptor in Immune Function
Buckley, N. E., Burbridge, D., Buranapramest, M., Ferguson, T., & Paau, R. Y. (2006) · Humana Press eBooks · doi:10.1385/1-59259-999-0:19 · Cited by 8
Chapter 4.5 The endocannabinoid system and anxiety responses
Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7
Ceccarini, J., Koole, M. J. B., & Laere, K. V. (2022) · Addiction Biology · doi:10.1111/adb.13167 · Cited by 7
Cannabinoid receptor type 1 in the aging gut regulates the mucosal permeability via miR-191-5p
Lee, Y., Kim, Y., Park, S., Heo, G., Chung, H. Y., & Im, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1241097 · Cited by 7
Kwee, C., van der Flier, F. E., Duits, P., van Balkom, A. J. L. M., Cath, D. C., & Baas, J. M. P. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06512-6 · Cited by 7
Rasser, P. E., Ehlkes, T., MinT Consortium, & Schall, U. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05494-9 · Cited by 7
Bortolato, M., Braccagni, G., Pederson, C. A., Floris, G., & Fite, P. J. (2024) · Aggression and Violent Behavior · doi:10.1016/j.avb.2024.101948 · Cited by 7
Ho, W., & Kolla, N. J. (2022) · Behavioral Sciences & the Law · doi:10.1002/bsl.2576 · Cited by 7
Saumell-Esnaola, M., Elejaga-Jimeno, A., Echeazarra, L., Roman, L. B., Barrondo, S., de Jesús, M. L., González‐Burguera, I., Gómez‐Caballero, A., Goicolea, M. A., Sallés, J., et al. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01914-1 · Cited by 7
Pearl‐Dowler, L., Posa, L., López-Canul, M., Teggin, A., & Gobbi, G. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110805 · Cited by 7
Automated one‐step radiosynthesis of the CB1 receptor imaging agent [18F]MK‐9470
Thomae, D., Morley, T. J., Hamill, T. G., Carroll, V. M., Papin, C., Twardy, N. M., Lee, H. S., Hargreaves, R. J., Baldwin, R. M., Tamagnan, G. D., et al. (2014) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3219 · Cited by 7
Liu, H., Patel, R. Y., & Doerksen, R. J. (2014) · MedChemComm · doi:10.1039/c4md00121d · Cited by 7
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway
Xie, J., Gizatullin, R. Z., Vukojević, V. B., & Leopardi, R. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.012 · Cited by 7
Riggs, N. R., Anthenien, A. M., & Leventhal, A. M. (2016) · Substance Use & Misuse · doi:10.3109/10826084.2015.1126742 · Cited by 7
Santos, V. R., Hammack, R. J., Wicker, E., N’Gouemo, P., & Forcelli, P. A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.595315 · Cited by 7
Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry
García‐Gutiérrez, M. S., Navarrete, F., Gasparyan, A., & Manzanares, J. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00006 · Cited by 7
Neurotransmitter Receptors in the Basal Ganglia
Emson, P. C., Waldvogel, H. J., & Faull, R. L. M. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00004-4 · Cited by 7
Self-citationMedical marijuana: a public health perspective
Desai, U., & Patel, P. (2013) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20130305 · Cited by 7
Cannabinoid-Based Drugs: Potential Applications in Addiction and Other Mental Disorders
Don, W., & Piomelli, D. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20150009 · Cited by 7
Helfand, A. I., Olsen, C. M., & Hillard, C. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081635 · Cited by 7
McDonald, A. J. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135503 · Cited by 7
Basavarajappa, B. S., Yalamanchili, R., Cooper, T. B., & Hungund, B. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_14 · Cited by 7
Endocannabinoids and Gastrointestinal Function
Darmani, N. A. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.pt6 · Cited by 7
Martínez-Torres, A. M., Cerdán-Centeno, K. T., Ramirez-Celis, C., Peniche-Zamudio, S., Durán-González, T. D. J., Roa-Gutierrez, C., Navarro‐Mabarak, C., & Morán, J. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0086 · Cited by 6
Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets
Pietra, A. D., & Russo, A. F. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00833 · Cited by 6
Overview of the Endocannabinoid System and Endocannabinoidome
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-89918-9_1 · Cited by 6
Orihuel, J., Capellán, R., Casquero‐Veiga, M., Soto‐Montenegro, M. L., Desco, M., Oteo, M., Ibanez-Moragues, M., Magro, N., Luján-Rodríguez, V. M., Morcillo, M. Á., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.05.005 · Cited by 6
Tyler, J. R., Park, Y., Lu, H., Roeder, N. M., Richardson, B., Gold, M. S., Blum, K., Pinhasov, A., Baron, D. A., & Thanos, P. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.038 · Cited by 6
Tudorancea, I. M., Stanciu, G. D., Solcan, C., Ciorpac, M., Szilagyi, A., Ababei, D. C., Gogu, M.-R., & Tamba, B.-I. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00313-8 · Cited by 6
Eykur notkun kannabis hættu á geðrofi og þróun geðklofa?
Jonsson, A. J., Birgisdóttir, H., Sigurðsson, E., & Sigurðsson, E. (2014) · Læknablaðið · doi:10.17992/lbl.2014.09.556 · Cited by 8
Antinori, S., & Fattore, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_2 · Cited by 6
Cong, Z., Fu, Y., Chen, N., Zhang, L., Yao, C., Wang, Y., Yao, Z., & Hu, B. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109595 · Cited by 6
Asher, M. J., McMullan, H. M., Dong, A., Li, Y., & Thayer, S. A. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000555 · Cited by 6
Subjective and Cognitive Effects of Cannabinoids in Marijuana Smokers
Ehrler, M. R., McGlade, E., & Yurgelun-Todd, D. A. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_7 · Cited by 6
Cannabinoid Receptor Agonists Inhibit Ca2+ Influx to Synaptosomes from Rat Brain
Yoshihara, S., Morimoto, H., Ohori, M., Yamada, Y., Abe, T., & Arisaka, O. (2006) · Pharmacology · doi:10.1159/000091228 · Cited by 6
Plant-derived contaminants in food
Dusemund, B., Soffers, A. E. M. F., & Rietjens, I. M. C. M. (2012) · Elsevier eBooks · doi:10.1533/9780857095794.2.394 · Cited by 6
The Neuropathology of Drug Abuse
Büttner, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00007-1 · Cited by 7
Association of CNR1 gene and cannabinoid 1 receptor protein in the human brain
Pak, K., Kantonen, T., Pekkarinen, L., Nuutila, P., & Nummenmaa, L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25149 · Cited by 7
Rentzsch, J., Kronenberg, G., Stadtmann, A., Neuhaus, A. H., Montag, C., Hellweg, R., & Jockers-Scherübl, M. C. (2016) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2016.10.004 · Cited by 6
Bobrov, М. Y., Безуглов, В. В., Хаспеков, Л. Г., Illarioshkin, S. N., Novosadova, E. V., & Grivennikov, I. A. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3782-2 · Cited by 6
Peri, L. M. D., Traber, R., Bolla, E., & Vita, A. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113731 · Cited by 6
The use of cannabinoids in multiple sclerosis
Teare, L., & Zajicek, J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.859 · Cited by 6
Endocannabinoids in the dentate gyrus
Frazier, C. J. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63019-2 · Cited by 6
Lian, J., Lareu, R. R., Patil, M., & Falasca, M. (2026) · Liver International · doi:10.1111/liv.70576 · Cited by 5
Nursing Care of the Patient Using Medical Marijuana
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30094-2 · Cited by 5
Laudermilk, L. T., Marusich, J. A., & Wiley, J. L. (2023) · Cardiovascular Toxicology · doi:10.1007/s12012-023-09810-9 · Cited by 5
Amygdala volume and depression symptoms in young adolescents who use cannabis
Wallace, A. L., Huestis, M., Sullivan, R. M., & Wade, N. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115150 · Cited by 5
Ajalin, R., Al‐Abdulrasul, H., Tuisku, J., Hirvonen, J., Lahdenpohja, S., Rinne, J. O., & Brück, A. (2024) · Movement Disorders · doi:10.1002/mds.30042 · Cited by 5
EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART
Faltraco, F., Lista, S., Garaci, F., & Hampel, H. (2012) · Cineca Institutional Research Information System (Tor Vergata University) · Cited by 5
Plescia, F., Plescia, F., Raffa, D., Cavallaro, A., Lavanco, G., Maggio, B., Raimondi, M. V., Daidone, G., Brancato, A., & Cannizzaro, C. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.06.004 · Cited by 5
Ribeiro, F. T., de Serro-Azul, M. I. S., Lorena, F. B., do Nascimento, B. P. P., Arnold, A. J. T., Barbosa, G., Ribeiro, M. O., & Cysneiros, R. M. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.560423 · Cited by 5
Evaluation of [18F]RoSMA-18-d6 as a CB2 PET Radioligand in Nonhuman Primates
Haider, A., Wang, L., Gobbi, L. B., Li, Y., Chaudhary, A. F., Zhou, X. M., Chen, J., Zhao, C., Rong, J., Xiao, Z., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00222 · Cited by 5
Muzik, O., Mann, T., Kopchick, J. J., Chowdury, A., Yacou, M. A., Vadgama, J., Bonello, D., & Diwadkar, V. A. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100035 · Cited by 5
Lorenzetti, V., Gaillard, A., McTavish, E., Grace, S., Rossetti, M. G., Batalla, A., Bellani, M., Brambilla, P., Chye, Y., Conrod, P., et al. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0204 · Cited by 5
Favoretto, C. A., Bertagna, N. B., Anjos-Santos, A., Loss, C. M., Rodolpho, B. T., Righi, T., Bezerra, F. R., Bianchi, P., & Cruz, F. C. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.037 · Cited by 5
Canonical Cannabinoid Receptors
Ehrlich, B., Patel, M., Zheng, X., & Glass, M. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_556 · Cited by 5
Self-citationImpact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients
Roser, P., Pichler, E. M., Habermeyer, B., Kawohl, W., & Juckel, G. (2018) · Pharmacopsychiatry · doi:10.1055/a-0573-9866 · Cited by 5
Cannabis sativa and pregnancy: a review
da Silva, I. A. N., Lima, D. A. S., Benevenuto, S. G. D. M., & Veras, M. M. (2019) · Biotemas · doi:10.5007/2175-7925.2019v32n2p1 · Cited by 5
Crume, T., Powers, S. E., Dufford, A. J., & Kim, P. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00419-6 · Cited by 5
Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy
Yao, I., Stein, E. S., & Maggio, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.002 · Cited by 5
Functional Organization of Dorsal Horn Interneurons
Willis, W. D., & Coggeshall, R. E. (2004) · Springer eBooks · doi:10.1007/978-1-4615-0035-3_7 · Cited by 5
Alijanpour, S., Ghasemzadeh, Z., Ebrahimi-Ghiri, M., & Zarrindast, M. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113886 · Cited by 5
Combinatorial approaches for treating neuropsychiatric social impairment
Don, W., Tsheringla, S., McPartland, J. C., & Allsop, S. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0051 · Cited by 6
Neuroinflammation and the Glial Endocannabinoid System
Benito, C., Tolón, R. M., Núñez, E., Pazos, M. R., & Romero, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_16 · Cited by 5
The endogenous cannabinoid system in schizophrenia
Sundram, S., Dean, B., & Copolov, D. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543630.011 · Cited by 5
Interaction of multiple gene variants and their effects on schizophrenia phenotypes.
Cheah, S.-Y., Lurie, J., Lawford, B., Young, R., Morris, C. P., & Voisey, J. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.08.015 · Cited by 5
Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists
Thomas, B. F. (2009) · Drug Development Research · doi:10.1002/ddr.20333 · Cited by 5
PET Imaging of the Endocannabinoid System
Terry, G. E., Raymont, V., & Horti, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_12 · Cited by 5
Opioid System Involvement in Cannabinoid Tolerance and Dependence
Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5
The therapeutic applications of cannabinoid agonists and antagonists
Petitet, F., & Impérato, A. (1998) · Emerging Drugs · doi:10.1517/14728214.3.1.39 · Cited by 5
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_2 · Cited by 4
Huang, P., Son, J. J., Arif, Y., John, J. A., Horne, L. K., Schantell, M. D., Springer, S. D., Rempe, M. P., Okelberry, H. J., Killanin, A. D., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106792 · Cited by 4
Metadata
- Authors
- Glass, M., Faull, R. L. M., & Dragunow, M.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Faull, R.L.M
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 77
- Issue
- 2
- Pages
- 299-318
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2037811574
- Cited by
- 1,052
- References
- 68
- Citations by year
- 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
- MeSH terms
- Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
